Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-05-30 Purchase | 2023-06-01 6:46 pm | Rain Oncology Inc. | RAIN | TANG KEVIN C TANG CAPITAL MANAGEMENT LLC TANG CAPITAL PARTNERS LP 10% Owner | 1,088,273 | $1.0648 | $1,158,764 | 3,740,341 (Indirect) | View |
| 2023-05-22 Sale | 2023-05-24 8:05 pm | Rain Oncology Inc. | RAIN | Boxer Capital LLC Boxer Asset Management Inc. LEWIS JOSEPH Davis Aaron I. See remarks. | 995,000 | $1.25 | $1,243,750 | 1,152,212 (Direct) | View |
| 2022-11-21 Purchase | 2022-11-23 5:45 pm | Rain Therapeutics Inc. | RAIN | BERGER FRANKLIN M Director | 122,000 | $8.0966 | $987,790 | 1,005,207 (Direct) | View |
| 2022-11-08 Purchase | 2022-11-14 4:17 pm | Rain Therapeutics Inc. | RAIN | BERGER FRANKLIN M Director | 42,881 | $5.83 | $249,996 | 883,207 (Direct) | View |
| 2022-11-08 Purchase | 2022-11-10 6:31 pm | Rain Therapeutics Inc. | RAIN | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Explanation of Responses 10% Owner | 1,710,358 | $5.83 | $9,971,387 | 3,649,733 (Indirect Direct) | View |
| 2022-11-04 Purchase | 2022-11-08 4:30 pm | Rain Therapeutics Inc. | RAIN | Davis Aaron I. Director | 972,212 | $5.83 | $5,667,996 | 5,649,427 (Indirect) | View |
| 2022-06-01 Purchase | 2022-06-02 4:05 pm | Rain Therapeutics Inc. | RAIN | Vellanki Avanish Chairman and CEO 10% Owner | 25,000 | $2.29 | $57,250 | 2,471,627 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-08-09 Option Award | 2023-08-11 9:17 pm | N/A 2033-08-09 | Rain Oncology Inc. | RAIN | Vellanki Avanish Chairman and CEO | 399,750 | $0 | 399,750 (Direct) | View |
| 2023-08-09 Option Award | 2023-08-11 9:16 pm | N/A 2033-08-09 | Rain Oncology Inc. | RAIN | Doebele Robert See Remarks | 149,100 | $0 | 149,100 (Direct) | View |
| 2023-08-09 Option Award | 2023-08-11 9:14 pm | N/A 2033-08-09 | Rain Oncology Inc. | RAIN | BERGER FRANKLIN M Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2023-08-09 Option Award | 2023-08-11 9:12 pm | N/A 2033-08-09 | Rain Oncology Inc. | RAIN | Radovich Peter Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2023-08-09 Option Award | 2023-08-11 9:11 pm | N/A 2033-08-09 | Rain Oncology Inc. | RAIN | Nguyen Tran Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2023-08-09 Option Award | 2023-08-11 9:09 pm | N/A 2033-08-09 | Rain Oncology Inc. | RAIN | Wolff Stefani Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2023-08-09 Option Award | 2023-08-11 9:07 pm | N/A 2033-08-09 | Rain Oncology Inc. | RAIN | Hrustanovic Gorjan Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2023-08-09 Option Award | 2023-08-11 9:05 pm | N/A 2033-08-09 | Rain Oncology Inc. | RAIN | Davis Aaron I. Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2023-08-09 Option Award | 2023-08-11 9:04 pm | N/A 2033-08-09 | Rain Oncology Inc. | RAIN | Atkisson Erik General Counsel and CCO | 60,251 | $0 | 60,251 (Direct) | View |
| 2023-08-09 Option Award | 2023-08-11 9:01 pm | N/A 2033-08-09 | Rain Oncology Inc. | RAIN | Bruce Josephine Principal Fin. & Acc. Officer | 10,800 | $0 | 10,800 (Direct) | View |
Ownership | 2023-06-09 4:05 pm | N/A N/A | Rain Oncology Inc. | RAIN | Bruce Josephine Principal Fin. & Acc. Officer | 0 | $0 | 22,386 (Direct) | View |
Ownership | 2023-06-01 6:44 pm | N/A N/A | Rain Oncology Inc. | RAIN | TANG KEVIN C TANG CAPITAL MANAGEMENT LLC TANG CAPITAL PARTNERS LP 10% Owner | 0 | $0 | 2,652,068 (Indirect) | View |
| 2023-03-02 Option Award | 2023-03-03 5:07 pm | N/A 2033-03-02 | Rain Oncology Inc. | RAIN | Atkisson Erik General Counsel and CCO | 120,000 | $0 | 120,000 (Direct) | View |
| 2023-02-15 Option Award | 2023-02-17 6:23 pm | N/A 2033-02-15 | Rain Oncology Inc. | RAIN | Cabatuan Nelson VP of Finance & Admin | 65,325 | $0 | 65,325 (Direct) | View |
| 2023-02-15 Option Award | 2023-02-17 6:21 pm | N/A 2033-02-15 | Rain Oncology Inc. | RAIN | BRYCE RICHARD PAUL Chief Medical Officer | 110,000 | $0 | 110,000 (Direct) | View |
| 2023-02-15 Option Award | 2023-02-17 6:18 pm | N/A 2033-02-15 | Rain Oncology Inc. | RAIN | Doebele Robert See Remarks | 123,325 | $0 | 123,325 (Direct) | View |
| 2023-02-15 Option Award | 2023-02-17 6:15 pm | N/A 2033-02-15 | Rain Oncology Inc. | RAIN | Vellanki Avanish Chairman and CEO | 318,600 | $0 | 318,600 (Direct) | View |
| 2022-06-01 Option Award | 2022-08-19 5:43 pm | N/A 2032-06-01 | Rain Therapeutics Inc. | RAIN | BERGER FRANKLIN M Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-01 Option Award | 2022-08-19 5:40 pm | N/A 2032-06-01 | Rain Therapeutics Inc. | RAIN | Davis Aaron I. Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-01 Option Award | 2022-08-19 5:38 pm | N/A 2032-06-01 | Rain Therapeutics Inc. | RAIN | Nguyen Tran Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-01 Option Award | 2022-08-19 5:38 pm | N/A 2032-06-01 | Rain Therapeutics Inc. | RAIN | Wolff Stefani Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-01 Option Award | 2022-08-19 5:35 pm | N/A 2032-06-01 | Rain Therapeutics Inc. | RAIN | Radovich Peter Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-01 Option Award | 2022-08-19 5:34 pm | N/A 2032-06-01 | Rain Therapeutics Inc. | RAIN | Hrustanovic Gorjan Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-07-06 Exercise | 2022-07-07 6:02 pm | N/A 2029-03-13 | Rain Therapeutics Inc. | RAIN | Doebele Robert See Remarks | 3,890 | $0 | 481,827 (Direct) | View |
| 2022-07-06 Exercise | 2022-07-07 6:02 pm | N/A N/A | Rain Therapeutics Inc. | RAIN | Doebele Robert See Remarks | 3,890 | $3.95 | 481,827 (Direct) | View |
| 2022-04-14 Gift | 2022-04-15 4:30 pm | N/A N/A | Rain Therapeutics Inc. | RAIN | Vellanki Avanish Chairman and CEO 10% Owner | 59,618 | $0 | 2,525,910 (Indirect) | View |
| 2022-04-13 Exercise | 2022-04-15 4:30 pm | N/A 2029-03-13 | Rain Therapeutics Inc. | RAIN | Doebele Robert See Remarks | 3,000 | $0 | 481,827 (Direct) | View |
| 2022-04-13 Exercise | 2022-04-15 4:30 pm | N/A N/A | Rain Therapeutics Inc. | RAIN | Doebele Robert See Remarks | 3,000 | $3.95 | 481,827 (Direct) | View |
| 2022-03-31 Exercise | 2022-04-04 4:15 pm | N/A 2029-03-13 | Rain Therapeutics Inc. | RAIN | Doebele Robert See Remarks | 2,000 | $0 | 481,827 (Direct) | View |
| 2022-03-31 Exercise | 2022-04-04 4:15 pm | N/A N/A | Rain Therapeutics Inc. | RAIN | Doebele Robert See Remarks | 2,000 | $3.95 | 481,827 (Direct) | View |
| 2022-03-11 Exercise | 2022-03-15 3:23 pm | N/A 2030-11-12 | Rain Therapeutics Inc. | RAIN | Vellanki Avanish President and CEO | 14,468 | $0 | 3,007,742 (Direct) | View |
| 2022-03-11 Exercise | 2022-03-15 3:23 pm | N/A N/A | Rain Therapeutics Inc. | RAIN | Vellanki Avanish President and CEO | 14,468 | $4 | 3,007,742 (Direct) | View |
| 2022-01-07 Option Award | 2022-02-04 4:45 pm | N/A 2032-01-07 | Rain Therapeutics Inc. | RAIN | Cabatuan Nelson See Remarks | 32,000 | $0 | 32,000 (Direct) | View |
| 2022-01-07 Option Award | 2022-02-04 4:40 pm | N/A 2032-01-07 | Rain Therapeutics Inc. | RAIN | BRYCE RICHARD PAUL Chief Medical Officer | 53,064 | $0 | 53,064 (Direct) | View |
| 2022-01-07 Option Award | 2022-02-04 4:35 pm | N/A 2032-01-07 | Rain Therapeutics Inc. | RAIN | Doebele Robert EVP, Chief Scientific Officer | 72,000 | $0 | 72,000 (Direct) | View |
| 2022-02-02 Option Award | 2022-02-04 4:30 pm | N/A 2032-02-02 | Rain Therapeutics Inc. | RAIN | Vellanki Avanish President and CEO | 182,300 | $0 | 182,300 (Direct) | View |